Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Ordinary Shares / American Depositary Shares
-
Shares outstanding
-
412,914,375
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
4,230,788
-
Shares change
-
+495,709
-
Total reported value, excl. options
-
$4,907,708
-
Value change
-
+$580,031
-
Number of buys
-
6
-
Number of sells
-
8
-
Price
-
$1.16
Institutional Holders of Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) as of Q2 2025
As of 30 Jun 2025 Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) had 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,230,788 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, ORBIMED ADVISORS LLC, SPHERA FUNDS MANAGEMENT LTD., Yelin Lapidot Holdings Management Ltd., Ikarian Capital, LLC, RHUMBLINE ADVISERS, KESTRA PRIVATE WEALTH SERVICES, LLC, BOOTHBAY FUND MANAGEMENT, LLC, JANE STREET GROUP, LLC, and BNP PARIBAS FINANCIAL MARKETS.
This table shows 14 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.